KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62 | -7.5% | 6,824 | +7.1% | 0.00% | 0.0% |
Q2 2023 | $67 | -20.2% | 6,373 | -7.2% | 0.00% | 0.0% |
Q1 2023 | $84 | -18.4% | 6,870 | -17.6% | 0.00% | 0.0% |
Q4 2022 | $103 | -99.9% | 8,339 | +3.0% | 0.00% | 0.0% |
Q3 2022 | $111,000 | -24.5% | 8,095 | +1.0% | 0.00% | 0.0% |
Q2 2022 | $147,000 | +19.5% | 8,016 | +4.8% | 0.00% | 0.0% |
Q1 2022 | $123,000 | -50.8% | 7,650 | -13.4% | 0.00% | -88.9% |
Q1 2021 | $250,000 | -19.9% | 8,831 | -7.6% | 0.01% | -25.0% |
Q4 2020 | $312,000 | +23.3% | 9,555 | +15.8% | 0.01% | +9.1% |
Q3 2020 | $253,000 | – | 8,250 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |